Skip to content

Randomized controlled trial study on intelligent electronic fire needle therapy for knee osteoarthritis

Randomized controlled trial study on intelligent electronic fire needle therapy for knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002490
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Medicine control group:Diclofenac diethylamine emulgel
Traditional fire needle group:Traditional fire needle
Intelligent electronic fire needle set:Intelligent electronic fire needle

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Complies with KOA Western Medicine diagnosis 2) KL staging levels I-III; 3) NRS score = 4 points; 4) 40 years old = age = 75 years old; 5) Written informed consent; 6) Agree to avoid the routine use of analgesics.

Exclusion criteria

Exclusion criteria: 1) Assess whether the knee joint has undergone previous knee joint surgery or any knee joint is currently undergoing any surgery; 2) Knee joint pain caused by other pathological reasons (such as meniscus tears, rheumatoid arthritis, joint cavity infections, malignant tumors, gout, lumbar and sacral diseases with lower limb symptoms, etc.); 3) Evaluate whether there is a history of arthroscopic examination of the knee joint within 1 year or intra-articular injection within 6 months; 4) Any knee joint has received acupuncture and moxibustion therapy in the past 6 months; 5) Severe acute or chronic organic or neuropsychiatric disorders; 6) Coagulation disorders (such as hemophilia); 7) Pacemakers or epilepsy; 8) Preparation for pregnancy, pregnancy or lactation period; 9) I have participated in other clinical studies within the past month.

Design outcomes

Primary

MeasureTime frame
effective response rate;

Secondary

MeasureTime frame
Numeric Rating Scale(NRS);Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC);Patient's global assessment(PGA);Expected value of treatment;Treatment satisfaction evaluation;Acceptability evaluation;Subject compliance;

Countries

China

Contacts

Public ContactBin Li

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

libin@bjzhongyi.com18910781852

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026